You have 9 free searches left this month | for more free features.

kl-a167

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple-negative Breast Cancer Trial in Changsha, Nanjing (SKB264, KL-A167)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Changsha, Hunan, China
  • +1 more
Jun 30, 2022

Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • KL-A167
  • +3 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022

NSCLC Trial in Guangzhou (SKB264, KL-A167, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 24, 2022

Classical Hodgkin Lymphoma Trial (KL-A167)

Unknown status
  • Classical Hodgkin Lymphoma
  • KL-A167
  • (no location specified)
Jun 26, 2018